Anji Pharmaceuticals
Improving Lives Globally
From our latest programs to our global strategies and partnerships, read how Anji is bridging science and culture to improve lives around the world
Anji Pharma Secures $70 Million to Deploy Dynamic Equity and Further Build a Global Medicines Company
Anji Pharma Launches Phase 3 Trial for ANJ900 to Treat Type 2 Diabetes Patients with Kidney Disease
Anji Pharma Adds Clinical Sites to Accelerate Clinical Development of Pradigastat for the Treatment of Functional Constipation